Susquehanna International Group’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.42M | Buy |
75,258
+51,590
| +218% | +$1.91M | ﹤0.01% | 5728 |
|
|
2025
Q4 | $996K | Sell |
23,668
-2,337
| -9% | -$94.2K | ﹤0.01% | 7204 |
|
|
2025
Q3 | $893K | Sell |
26,005
-582,840
| -96% | -$16.7M | ﹤0.01% | 7608 |
|
|
2025
Q2 | $16.5M | Buy |
608,845
+72,441
| +14% | +$2.1M | ﹤0.01% | 2217 |
|
|
2025
Q1 | $15.9M | Buy |
536,404
+487,614
| +999% | +$18.6M | ﹤0.01% | 1968 |
|
|
2024
Q4 | $1.93M | Buy |
48,790
+18,930
| +63% | +$717K | ﹤0.01% | 5387 |
|
|
2024
Q3 | $1.02M | Sell |
29,860
-99,092
| -77% | -$2.79M | ﹤0.01% | 6746 |
|
|
2024
Q2 | $2.79M | Buy |
128,952
+98,688
| +326% | +$2.07M | ﹤0.01% | 4448 |
|
|
2024
Q1 | $671K | Sell |
30,264
-94,457
| -76% | -$2.3M | ﹤0.01% | 7796 |
|
|
2023
Q4 | $3.43M | Buy |
124,721
+84,657
| +211% | +$2.04M | ﹤0.01% | 4350 |
|
|
2023
Q3 | $895K | Buy |
40,064
+9,021
| +29% | +$232K | ﹤0.01% | 6881 |
|
|
2023
Q2 | $791K | Sell |
31,043
-87,067
| -74% | -$2.11M | ﹤0.01% | 7224 |
|
|
2023
Q1 | $2.63M | Buy |
118,110
+11,207
| +10% | +$271K | ﹤0.01% | 4581 |
|
|
2022
Q4 | $2.54M | Sell |
106,903
-37,706
| -26% | -$876K | ﹤0.01% | 4291 |
|
|
2022
Q3 | $2.4M | Buy |
144,609
+108,215
| +297% | +$2.44M | ﹤0.01% | 4562 |
|
|
2022
Q2 | $724K | Sell |
36,394
-27,766
| -43% | -$561K | ﹤0.01% | 7336 |
|
|
2022
Q1 | $1.77M | Sell |
64,160
-14,310
| -18% | -$409K | ﹤0.01% | 5753 |
|
|
2021
Q4 | $3.23M | Buy |
78,470
+23,334
| +42% | +$1.03M | ﹤0.01% | 4515 |
|
|
2021
Q3 | $2.56M | Buy |
55,136
+6,839
| +14% | +$298K | ﹤0.01% | 5293 |
|
|
2021
Q2 | $1.93M | Sell |
48,297
-12,024
| -20% | -$514K | ﹤0.01% | 5996 |
|
|
2021
Q1 | $3.24M | Sell |
60,321
-35,053
| -37% | -$2.02M | ﹤0.01% | 4787 |
|
|
2020
Q4 | $4.67M | Buy |
95,374
+54,333
| +132% | +$2.52M | ﹤0.01% | 3511 |
|
|
2020
Q3 | $1.33M | Buy |
41,041
+17,435
| +74% | +$554K | ﹤0.01% | 5430 |
|
|
2020
Q2 | $611K | Sell |
23,606
-25,864
| -52% | -$644K | ﹤0.01% | 6943 |
|
|
2020
Q1 | $1.2M | Sell |
49,470
-15,384
| -24% | -$387K | ﹤0.01% | 4961 |
|
|
2019
Q4 | $1.81M | Sell |
64,854
-8,988
| -12% | -$233K | ﹤0.01% | 4489 |
|
|
2019
Q3 | $1.77M | Sell |
73,842
-2,161
| -3% | -$57.5K | ﹤0.01% | 4457 |
|
|
2019
Q2 | $2.17M | Buy |
+76,003
| New | +$1.9M | ﹤0.01% | 4021 |
|
|
2019
Q1 | – | Sell |
-15,946
| Closed | -$305K | – | 9901 |
|
|
2018
Q4 | $201K | Buy |
+15,946
| New | +$189K | ﹤0.01% | 7743 |
|
|
2018
Q2 | – | Sell |
-14,554
| Closed | -$81K | – | 10485 |
|
|
2018
Q1 | $81K | Buy |
+14,554
| New | +$90.1K | ﹤0.01% | 8784 |
|
|
2017
Q4 | – | Sell |
-39,293
| Closed | -$292K | – | 9947 |
|
|
2017
Q3 | $345K | Buy |
39,293
+19,407
| +98% | +$158K | ﹤0.01% | 7157 |
|
|
2017
Q2 | $166K | Sell |
19,886
-30,951
| -61% | -$252K | ﹤0.01% | 8437 |
|
|
2017
Q1 | $467K | Sell |
50,837
-48,792
| -49% | -$399K | ﹤0.01% | 6593 |
|
|
2016
Q4 | $771K | Buy |
99,629
+76,136
| +324% | +$569K | ﹤0.01% | 6071 |
|
|
2016
Q3 | $179K | Sell |
23,493
-12,214
| -34% | -$69.1K | ﹤0.01% | 7662 |
|
|
2016
Q2 | $180K | Sell |
35,707
-6,437
| -15% | -$34.5K | ﹤0.01% | 7685 |
|
|
2016
Q1 | $228K | Buy |
+42,144
| New | +$249K | ﹤0.01% | 7757 |
|
Other funds holding VCYT
VPM
VCM
AIM
Susquehanna International Group's VCYT Position: Q1 2026 in Review
Susquehanna International Group increased its Veracyte (VCYT) stake by 218% in Q1 2026, buying an estimated $1.91M and bringing the position to 75,258 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #5728.
Susquehanna International Group first reported a position in VCYT in Q1 2016 and has held it in 37 quarters since. The position peaked at $16.5M in Q2 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Susquehanna International Group held 75,258 shares of Veracyte worth $2.42M as of Q1 2026.
- Susquehanna International Group bought 51,590 Veracyte shares in Q1 2026, an estimated $1.91M.
- Veracyte made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5728 holding.
- Susquehanna International Group first reported a position in Veracyte in Q1 2016 and has held it in 37 quarters since.
- Susquehanna International Group's Veracyte position peaked at $16.5M in Q2 2025.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.